Front Page News

9th Annual “Hope on the Hill” Congressional Dinner

November 26, 2019
Posted in ,

Just one more week until the 9th Annual “Hope on the Hill” Congressional Dinner in Washington D.C.! Next Tuesday, December 3rd, SMA families and advocates, […]

Read More ›

Cure SMA and Genentech Partner to Provide Travel Support to Adults with SMA for the 2020 Annual SMA Conference

November 25, 2019
Posted in ,

Cure SMA is thrilled to announce that we will, once again, be offering scholarship opportunities to adults with SMA (18 years of age and older) […]

Read More ›

Community Statement from Genentech: FDA Grants Priority Review to Risdiplam for Spinal Muscular Atrophy

November 25, 2019
Posted in

Genentech, a member of the Roche Group, today announced that the U.S. Food and Drug Administration (FDA) has accepted the New Drug Application (NDA) and […]

Read More ›

SMA Concordance Among Siblings Published in the Journal of Neuromuscular Diseases

November 21, 2019
Posted in ,

Earlier this month, an article was published in the Journal of Neuromuscular Diseases titled, “Spinal Muscular Atrophy (SMA) Subtype Concordance in Siblings: Findings from the […]

Read More ›

Caring for the Caregiver by Brynne Willis

November 20, 2019
Posted in ,

Many consider the deepest expression of love is being a caregiver. Providing for someone’s needs is incredibly special and rewarding to the one who is […]

Read More ›

Scholar Rock Reports Preliminary Pharmacokinetic and Pharmacodynamic Data from TOPAZ Phase 2 Trial of SRK-015 for the Treatment of Patients with Spinal Muscular Atrophy

November 19, 2019
Posted in ,

Scholar Rock today announced preliminary pharmacokinetic (PK) and pharmacodynamic (PD) results from the TOPAZ Phase 2 proof-of-concept trial of SRK-015 for the treatment of patients […]

Read More ›

Team Cure SMA Raises Over $45,000 in the New York City Marathon

November 18, 2019
Posted in ,

Fifteen Team Cure SMA runners successfully raised over $45,000 for Cure SMA while running in the 2019 TCS New York City Marathon on November 3, […]

Read More ›

Genentech’s Risdiplam Meets Primary Endpoint in Pivotal SUNFISH Trial in People With Type 2 or 3 Spinal Muscular Atrophy

November 11, 2019
Posted in ,

Genentech, a member of the Roche Group, today announced positive data from the pivotal Part 2 of the SUNFISH study evaluating risdiplam in people aged […]

Read More ›

A Tiny Warrior: Winnie Stanley’s Story

November 6, 2019
Posted in ,

This guest post is written by April Leiffer Henry If you ask 4-year-old Winnie Stanley what she wants to be when she grows up, she’ll […]

Read More ›

Community Spotlight: Angela Wrigglesworth

October 31, 2019
Posted in , ,

October has been National Disability Employment Awareness Month, and throughout the month, you have heard stories about adults in the workforce who live with SMA. […]

Read More ›
Scroll to Top